Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:328-335, doi:10.1016/S0735-1097(03)00625-9
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diamant, M.
Right arrow Articles by Radder, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diamant, M.
Right arrow Articles by Radder, J. K.

Diastolic dysfunction is associatedwith altered myocardial metabolism inasymptomatic normotensive patientswith well-controlled type 2 diabetes mellitus

Michaela Diamant, MD, PhD*||,*, Hildo J. Lamb, PhD{dagger}, Ymte Groeneveld, MD, PhD{ddagger}, Edwin L. Endert{dagger}, Jan W. A. Smit, MD, PhD*, Jeroen J. Bax, MD, PhD§, Johannes A. Romijn, MD, PhD*, Albert de Roos, MD, PhD{dagger} and Jasper K. Radder, MD, PhD*

* Departments of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
{dagger} Radiology, Leiden University Medical Center, Leiden, The Netherlands
{ddagger} General Practice, Leiden University Medical Center, Leiden, The Netherlands
§ Cardiology, Leiden University Medical Center, Leiden, The Netherlands
|| Department of Endocrinology/Diabetes Center, VU University Medical Center, Amsterdam, The Netherlands



View larger version (17K):

[in a new window]
 
Figure 1 (A) Mean ± SD myocardial phosphocreatine to adenosine-triphosphate (PCr/ATP) ratios in type 2 diabetic patients (solid bar) and controls (open bar). *p < 0.01. (B) Representative phosphorus-31 magnetic resonance spectroscopy (31P-MRS) obtained at rest from the anterior left ventricular wall of a patient (upper panel) and healthy subject (lower panel). The peaks of PCr, ATP, and inorganic phosphate (Pi) plus 2,3-diphospho-glycerate (2,3-DPG) are identified in the upper panel. Myocardial PCr/ATP ratios, as presented below the 31P-MRS, were corrected for partial saturation effects and blood-ATP contamination, and line broadening of 15 Hz was applied.

 


View larger version (14K):

[in a new window]
 
Figure 2 The association between myocardial phosphocreatine/adenosine-triphosphate (PCr/ATP) and E peak filling rate (A) and E acceleration peak (B), representing indexes of diastolic function, in type 2 diabetic patients (solid dots) and healthy controls (open dots). See also Table 3 and text.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement